Efficacy and safety of aztreonam versus tobramycin for aerobic gram-negative bacilli lower respiratory tract infections.
Aztreonam therapy was evaluated for the management of 80 patients with gram-negative bacilli lower respiratory tract infections. Study results confirmed its efficacy and safety for this indication.